FMS - Fresenius Medical Care AG & Co. KGaA

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
16,835,128
16,547,000
17,784,000
17,030,495
15,309,579
Cost of Revenue
11,591,168
11,392,000
11,780,000
11,534,640
10,433,527
Gross Profit
5,243,960
5,155,000
6,004,000
5,495,855
4,876,052
Operating Expenses
Research Development
138,704
134,000
131,000
154,036
128,052
Selling General and Administrative
2,989,408
2,865,000
3,578,000
2,895,308
2,647,941
Total Operating Expenses
3,128,112
2,999,000
3,709,000
3,049,344
2,775,993
Operating Income or Loss
2,115,848
2,156,000
2,295,000
2,446,511
2,100,059
Interest Expense
506,825
448,000
397,000
430,731
464,647
Total Other Income/Expenses Net
81,782
882,000
67,000
61,805
28,354
Income Before Tax
1,842,006
2,737,000
2,008,000
2,122,275
1,770,782
Income Tax Expense
358,822
511,000
454,000
649,424
569,833
Income from Continuing Operations
1,483,184
2,226,000
1,554,000
1,472,851
1,200,949
Net Income
1,233,917
1,982,000
1,280,000
1,181,894
941,185
Net Income available to common shareholders
1,233,917
1,982,000
1,280,000
1,181,894
941,185
Reported EPS
Basic
-
3.23
2.08
1.93
1.55
Diluted
-
3.23
2.08
1.93
1.55
Weighted average shares outstanding
Basic
-
612,650
613,127
611,497
608,880
Diluted
-
614,550
614,567
612,515
609,840
EBITDA
-
3,910,000
3,141,000
3,289,906
2,891,240